Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 6, 2014, Pages 1744-1750

  Ironmonger, Dean ^a   Edeghere, Obaghe ^a   Bains, Amardeep ^a   Loy, Richard ^a   Woodford, Neil ^a   Hawkey, Peter M ^b,c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Antibiotic resistance; Epidemiology; Gram negative; Microbiology; UTIs

Indexed keywords

CARBAPENEM DERIVATIVE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; COMMUNITY; ESCHERICHIA COLI; HOSPITAL; HUMAN; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; UNITED KINGDOM; URINARY TRACT; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; RETROSPECTIVE STUDY; URINARY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENGLAND; EPIDEMIOLOGICAL MONITORING; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 84930510916     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv043     Document Type: Article

References (26)

1. CDC. Antibiotic Resistance Threats in the United States, 2013. http://www. cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.
2. WHO. Antimicrobial Resistance: Global Report on Surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/.
3. Chief Medical Officer. Annual Report of the Chief Medical Officer. Volume Two, 2011. Infections and the Rise of Antimicrobial Resistance. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/138331/CMO_Annual_Report_Volume_2_2011.pdf.
4. Department of Health. UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf.
5. Ironmonger D, Edeghere O, Gossain S et al. AmWeb: a novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients. J Antimicrob Chemother 2013;68:2406-13.
6. Gupta K, Sahm DF, Mayfield D et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001;33:89-94.
7. Karlowsky JA, Lagace-Wiens PR, Simner PJ et al. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother 2011;55:3169-75.
8. Office for National Statistics. 2011 Census for England and Wales. http://www.ons.gov.uk/ons/guide-method/census/2011/index.html?utm_source= twitterfeed&utm_medium=twitter.
9. Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infection (ARHAI). Minutes from Meeting on the 28th March 2014. https://app.box.com/ARHAI-Minutes-Papers/1/2152373734/18606239996/1.
10. HPA. Guidance to Diagnostic Laboratories. Laboratory Detection & Reporting of Bacteria with Extended-Spectrum b-Lactamases. http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa. org.uk/webc/hpawebfile/hpaweb_c/1194947314416.
11. BSAC. BSAC Methods for Antimicrobial Susceptibility Testing Version 12. http://bsac.org.uk/wp-content/uploads/2012/02/Version-12-Apr-2013_final. pdf.
12. BSAC. BSAC Methods for Antimicrobial Susceptibility Testing Version 10. http://bsac.org.uk/wp-content/uploads/2012/02/Version-10-2011-final. pdf.
13. EUCAST. Breakpoint Tables for Bacteria. http://www.eucast.org/clinical_breakpoints/.
14. Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008;7:13.
15. Hayward AC, Goldsmith K, Johnson AM. Report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Surveillance Subgroup. J Antimicrob Chemother 2007;60 Suppl 1: i33-42.
16. Livermore DM. Fourteen years in resistance. Int J Antimicrob Agents 2012;39:283-94.
17. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602.
18. Robert J, Pantel A, Merens A et al. Incidence rates of carbapenemaseproducing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12. J Antimicrob Chemother 2014;69:2706-12.
19. PHE. UK Standards for Microbiology Investigations. Laboratory Detection and Reporting of Bacteria with Carbapenem-Hydrolysing b-Lactamases (Carbapenemases). 8 May 2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/344071/P_8i1.1.pdf.
20. Livermore DM, Hope R, Reynolds R et al. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 2013; 68:2667-74.
21. PHE. English Surveillance Programme Antimicrobial Utilisation and Resistance (ESPAUR) Report. 10 October 2014. https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobialutilisation-and-resistance-espaur-report.
22. PHE. Mandatory Surveillance of MRSA, MSSA, and Escherichia coli Bacteraemia and Clostridium difficile Infection. http://data.gov.uk/dataset/mandatory_surveillance:of_mrsa_mssa_and_escherichia_coli_ bacteraemia_and_clostridium_difficile_infec.
23. Cabot G, Ocampo-Sosa AA, Tubau F et al. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob Agents Chemother 2011;55:1906-11.
24. Hillier S, Bell J, Heginbothom M et al. When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data. J Antimicrob Chemother 2006;58:1303-6.
25. UK NEQAS for Microbiology. http://www.ukneqasmicro.org.uk/.
26. PHE. West Midlands Community Antimicrobial Resistance Bulletin. http://www.hpa-wm.co.uk/WMAMRPrimaryCareBulletin/.